Skip to main content
Log in

Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Although adiponectin levels are associated with obesity and insulin insensitivity, the role of adiponectin in the progression to diabetes in non-obese subjects is unclear. Therefore, 289 women aged 50–80 years without previous history of diabetes or impaired glucose tolerance (IGT) were studied. They were classified as normal glucose tolerance (NGT), IGT or diabetes based on WHO criteria. Insulin sensitivity (S) and beta cell function (B) indices were calculated using homeostasis model assessment (HOMA). In obese women with BMI ≥ 25 kg/m2 (n = 161), there were declines in HOMA-%S (< 0.001), HOMA-%B (< 0.05) and circulating adiponectin (< 0.001) across glucose tolerance status. In non-obese women with BMI < 25 kg/m2 (n = 128), there was no significant change in HOMA-%S in women with IGT and diabetes as compared to women with NGT. However, HOMA-%B (< 0.05) and serum adiponectin levels (< 0.001) were significantly decreased across glucose tolerance. Serum adiponectin levels were correlated to HOMA-%S in both obese and non-obese women while negative correlations between circulating adiponectin and HOMA-%B were demonstrated only in obese women. We have demonstrated in the present study the predominant role of beta cell dysfunction as compared to that of insulin resistance in the deterioration of glucose tolerance in non-obese women. Circulating adiponectin appears to be inversely related to beta cell dysfunction in addition to insulin resistance only in obese women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, E. Ravussin, W.C. Knowler, P.H. Bennett, C. Bogardus, Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329, 1988–1992 (1993)

    Article  CAS  PubMed  Google Scholar 

  2. R.A. Sicree, P.Z. Zimmet, H.O. King, J.S. Coventry, Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36, 179–186 (1987)

    Article  CAS  PubMed  Google Scholar 

  3. S. Lillioja, D.M. Mott, B.V. Howard, P.H. Bennett, H. Yki-Jarvinen, D. Freymond, et al., Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. 318, 1217–1225 (1988)

    Article  CAS  PubMed  Google Scholar 

  4. C. Weyer, P.A. Tataranni, C. Bogardus, R.E. Pratley, Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24, 89–94 (2001)

    Article  CAS  PubMed  Google Scholar 

  5. C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104, 787–794 (1999)

    Article  CAS  PubMed  Google Scholar 

  6. B. Ludvik, J.J. Nolan, J. Baloga, D. Sacks, J. Olefsky, Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44, 1121–1125 (1995)

    Article  CAS  PubMed  Google Scholar 

  7. K.H. Yoon, J.H. Lee, J.W. Kim, J.H. Cho, Y.H. Choi, S.H. Ko, P. Zimmet, H.Y. Son, Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681–1688 (2006)

    Article  PubMed  Google Scholar 

  8. D.J. Kim, M.S. Lee, K.W. Kim, M.K. Lee, Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism 50, 590–593 (2001)

    Article  CAS  PubMed  Google Scholar 

  9. K. Matsumoto, S. Miyake, M. Yano, Y. Ueki, Y. Yamaguchi, S. Akazawa, et al., Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20, 1562–1568 (1997)

    Article  CAS  PubMed  Google Scholar 

  10. M. Fukushima, M. Usami, M. Ikeda, Y. Nakai, A. Taniguchi, T. Matsuura, et al., Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53, 831–835 (2004)

    Article  CAS  PubMed  Google Scholar 

  11. N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, et al., Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102, 1296–1301 (2000)

    CAS  PubMed  Google Scholar 

  12. W.S. Yang, C.Y. Jeng, T.J. Wu, S. Tanaka, T. Funahashi, Y. Matsuzawa, et al., Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25, 376–380 (2002)

    Article  CAS  PubMed  Google Scholar 

  13. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, et al., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595–1599 (2000)

    CAS  PubMed  Google Scholar 

  14. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, et al., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001)

    Article  CAS  PubMed  Google Scholar 

  15. W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C.L. Chao, C.L. Chen, T.Y. Tai, L.M. Chuang, Plasma adiponectin levels in overweight and obese Asians. Obes. Res. 10, 1104–1110 (2002)

    Article  CAS  PubMed  Google Scholar 

  16. World Health Organization, Obesity. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, ed. by World Health Organization, Western Pacific Region (World Health Organization, Geneva, 2000)

  17. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 27(Suppl 1), S5–S10 (2004)

    Google Scholar 

  18. T.M. Wallace, J.C. Levy, D.R. Matthews, Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495 (2004)

    Article  PubMed  Google Scholar 

  19. C.C. Jensen, M. Cnop, R.L. Hull, W.Y. Fujimoto, S.E. Kahn, Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S Diabetes 51, 2170–2178 (2002)

    Article  CAS  PubMed  Google Scholar 

  20. Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, T. Saruta, Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J. Clin. Endocrinol. Metab. 89, 87–90 (2004)

    Article  CAS  PubMed  Google Scholar 

  21. R.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, P.A. Tataranni, et al., Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57–58 (2002)

    Article  CAS  PubMed  Google Scholar 

  22. B.B. Duncan, M.I. Schmidt, J.S. Pankow, H. Bang, D. Couper, C.M. Ballantyne, et al., Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53, 2473–2478 (2004)

    Article  CAS  PubMed  Google Scholar 

  23. F. Bacha, R. Saad, N. Gungor, S.A. Arslanian, Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27, 547–552 (2004)

    Article  CAS  PubMed  Google Scholar 

  24. T.M. Wallace, J.C. Levy, D.R. Matthews, An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet. Med. 21, 568–576 (2004)

    Article  CAS  PubMed  Google Scholar 

  25. E. Zeender, K. Maedler, D. Bosco, T. Berney, M.Y. Donath, P.A. Halban, Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. J. Clin. Endocrinol. Metab. 89, 5059–5066 (2004)

    Article  CAS  PubMed  Google Scholar 

  26. Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L.J. Mandarino, R.A. DeFronzo, Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 89, 4312–4319 (2004)

    Article  CAS  PubMed  Google Scholar 

  27. K. Maedler, P. Sergeev, F. Ris, J. Oberholzer, H.I. Joller-Jemelka, G.A. Spinas, et al., Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851–860 (2002)

    CAS  PubMed  Google Scholar 

  28. R.H. Unger, Y.T. Zhou, Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1), S118–S121 (2001)

    Article  CAS  PubMed  Google Scholar 

  29. I. Rakatzi, H. Mueller, O. Ritzeler, N. Tennagels, J. Eckel, Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47, 249–258 (2004)

    Article  CAS  PubMed  Google Scholar 

  30. K. Staiger, N. Stefan, H. Staiger, M.D. Brendel, D. Brandhorst, R.G. Bretzel, F. Machicao, M. Kellerer, M. Stumvoll, A. Fritsche, Häring HU, Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J. Clin. Endocrinol. Metab. 90, 6707–6713 (2005)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by the Thailand Research Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to La-or Chailurkit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chailurkit, Lo., Chanprasertyothin, S., Jongjaroenprasert, W. et al. Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women. Endocr 33, 84–89 (2008). https://doi.org/10.1007/s12020-008-9057-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-008-9057-y

Keywords

Navigation